Aspiriant Defensive Allocation RMDFX
- NAV / 1-Day Return 10.70 / +0.09 %
- Total Assets 1.2 Bil
-
Adj. Expense Ratio
- Expense Ratio 3.290%
- Distribution Fee Level High
- Share Class Type No Load
- Category Multistrategy
- Alt Style Correlation / Relative Volatility High/Low
- Min. Initial Investment —
- Status Open
- TTM Yield 3.56%
- Turnover 21%
USD | NAV as of Apr 24, 2024 | 1-Day Return as of Apr 24, 2024, 12:05 AM GMT+0
Morningstar’s Analysis RMDFX
There is no Morningstar’s Analysis data available.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 91.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
GMO Benchmark-Free Allocation IV | 31.49 | 392.5 Mil | — |
Lyxor/Bridgewater Fd Ltd B USD Acc | 12.08 | 150.6 Mil | — |
JPMorgan Global Allocation R6 | 10.05 | 125.2 Mil | — |
Gmo Investments Icav - Gmo Equity Dislocation | 7.29 | 90.8 Mil | — |
JPMorgan Prime Money Market Morgan | 6.12 | 76.3 Mil | Cash and Equivalents |
Millennium Intl -G- | 5.94 | 74.1 Mil | — |
iShares Gold Trust | 5.22 | 65.1 Mil | — |
Eaton Vance Glbl Macro Abs Ret Advtg R6 | 5.01 | 62.4 Mil | — |
Lazard Rathmore Alternative E Acc USD | 4.89 | 61.0 Mil | — |
BlackRock Event Driven Equity Instl | 4.85 | 60.4 Mil | — |